The aim of this proposal is to elucidate T cell receptor (TCR) crossreactivity at the molecular level. The unique model developed involves crossreactive TCR recognition of the immunodominant viral peptide coupled to two very closely related class I MHC variants. TCRs to be studied share the same TCRbeta chains, but some see only one of the complexes (monospecific recognition) while others see both (crossreactive recognition). This indicates that the TCRalpha chain must play a decisive role in crossreactivity. TCR sequencing, generation and analysis of single TCR chain transgenic (scTCRTg mice), Crystal structure determination and TCR mutagenesis will be used to dissect the molecular contacts that permit crossreactivity, a phenomenon underlying alloreactivity, tolerance induction, transplant rejection and autoimmunity.
The aims are: 1. To analyze functional reactivity and TCR sequence of crossreactive and monospecific CTL clones from normal and scTCRTg mice and establish the preliminary contacts that define crossreactive and monospecific TCR:peptide:MHC interactions for closely related TCRs. 2. To determine the x-ray structures of the monospecific and crossreactive TCRs with the appropriate pep:MHC complexes, and use site-directed mutagenesis to definitively dissect crossreactive recognition.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA086803-06
Application #
6701818
Study Section
Immunobiology Study Section (IMB)
Program Officer
Mccarthy, Susan A
Project Start
2000-02-01
Project End
2005-01-31
Budget Start
2004-02-01
Budget End
2005-01-31
Support Year
6
Fiscal Year
2004
Total Cost
$299,272
Indirect Cost
Name
Oregon Health and Science University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Lang, Anna; Nikolich-Zugich, Janko (2005) Development and migration of protective CD8+ T cells into the nervous system following ocular herpes simplex virus-1 infection. J Immunol 174:2919-25
Nikolich-Zugich, Janko; Fremont, Daved H; Miley, Michael J et al. (2004) The role of mhc polymorphism in anti-microbial resistance. Microbes Infect 6:501-12
Miley, Michael J; Messaoudi, Ilhem; Metzner, Beatrix M et al. (2004) Structural basis for the restoration of TCR recognition of an MHC allelic variant by peptide secondary anchor substitution. J Exp Med 200:1445-54
Lybarger, Lonnie; Yu, Y Y Lawrence; Miley, Michael J et al. (2003) Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptide. J Biol Chem 278:27105-11
Alexander, Jennifer M; Nelson, Christopher A; van Berkel, Victor et al. (2002) Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 111:343-56
Messaoudi, Ilhem; Guevara Patino, Jose A; Dyall, Ruben et al. (2002) Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. Science 298:1797-800
Lam, J; Nelson, C A; Ross, F P et al. (2001) Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity. J Clin Invest 108:971-9
Messaoudi, I; LeMaoult, J; Metzner, B M et al. (2001) Functional evidence that conserved TCR CDR alpha 3 loop docking governs the cross-recognition of closely related peptide:class I complexes. J Immunol 167:836-43